Tissue infiltrating T lymphocytes in health and disease: new approaches to dissect identity, geography and function of tissutal T cells and to discover new targets for precision immunotherapy
The major focus of my research is the dissection of the heterogeneity of the T cell population infiltrating solid tumors, and how this differs and evolves between primary tumors and metastases. Our knowledge of the human immune system is essentially based on the analysis of lymphocytes isolated from peripheral blood. However, the vast majority (>99%) of effector T lymphocytes reside in peripheral tissues where they contribute to homeostasis or mediate immunopathology in autoimmunity or cancer through poorly defined inflammatory and anti-inflammatory programs. The identification of molecular targets to modulate tissutal T cells is a promising area of investigation with the potential to lead to transformative therapies. In cancer and autoimmunity, tissue T cell subsets exert opposite roles but are pathogenetic in both cases, we can thus describe “loss of function” or “gain of function” of the various T cells subsets in vivo. We are combining single-cell “omics” and in situ analyses to provide an unbiased molecular and geographical landscape of lymphocytes infiltrating primary or metastatic tumors (lung and colon), or inflamed tissues (Rheumatoid Arthritis and Crohn). We are identifying tissue- and disease-specific T-cell transcripts, which are complemented by multiplexed RNA-FISH to obtain maps of spatial networks of tissue T cells. The newly identified genes are then validated with gene and protein expression analyses on large panels of human tissues, and are silenced in T cells in vitro to assess their relevance in T cell function. The intersection of these datasets, the fine dissection of the regulatory networks and modelling of T cell clonal expansion will be used to investigate T cell identity, function and plasticity. In so doing we can differentiate proteins representing effective pharmacological targets because of their necessary and direct role in maintaining T cell functional states from those that may be only sufficient, thus representing less important targets. This approach will generate transformative knowledge on tissutal immune regulation thus identifying new targets for precision immunotherapy.
Projects
- Phenotypic, molecular and functional characterization of tumor infiltrating T cell complexity and heterogeneity in primary tumors and metastases
- Establishment of tumoroid models based on co-culturing of organoids (derived from human tumors) and autologous T lymphocytes to study the interplay between tumor cells and immune cells
Team
Nome / Name | Ruolo / Role | |
---|---|---|
Mattia Battistella | Bioinformatician | battistella@ingm.org |
Valeria Bevilacqua | Post Doc | bevilacqua@ingm.org |
Maria Grazia Ceraolo | Post Doc | ceraolo@ingm.org |
Tanya Fabbris | Lab Manager | fabbris@ingm.org |
Andrea Favalli | Predoctoral student | favalli@ingm.org |
Eugenia Galeota | Bioinformatician | galeota@ingm.org |
Andrea Gobbini | Researcher | gobbini@ingm.org |
Renata Grifantini | Group Leader | grifantini@ingm.org |
Paola Gruarin | Staff Scientist | gruarin@ingm.org |
Samuele Notarbartolo | Junior PI | notarbartolo@ingm.org |
Elisa Pesce | Post Doc | pesce@ingm.org |
Maria Lucia Sarnicola | Laboratory Technician | sarnicola@ingm.org |
Serena Curti | Staff Scientist | curti@ingm.org |
Publications
- Dual Activation-Induced Marker Combinations Efficiently Identify and Discern Antigen-Specific and Bystander-Activated Human CD4+ T Cells
Ceraolo MG, Leccese M, Cassotta A, Triolo S, Bombaci M, Coluccio E, Prati D, Ungaro R, Abrignani S, Bandera A, Sallusto F, Lanzavecchia A, Notarbartolo S.
Eur J Immunol. 2025 Feb;55(2):e202451404. - High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development.
Bombaci M, Fassi EMA, Gobbini A, Mileto D, Cassaniti I, Pesce E, Casali E, Mancon A, Sammartino J, Ferrari A, Percivalle E, Grande R, Marchisio E, Gismondo MR, Abrignani S, Baldanti F, Colombo G, Grifantini R.
J Med Virol. 2024 Sep;96(9):e29923. - Early-onset cancers: Biological bases and clinical implications.
Mauri G, Patelli G, Sartore-Bianchi A, Abrignani S, Bodega B, Marsoni S, Costanzo V, Bachi A, Siena S, Bardelli A.
Cell Rep Med. 2024 Sep 17;5(9):101737. - LINE1 modulate human T cell function by regulating protein synthesis during the life span
Burattin FV, Vadalà R, Panepuccia M, Ranzani V, Crosti M, Colombo FA, Ruberti C, Erba E, Prati D, Nittoli T, Montini G, Ronchi A, Pugni L, Mosca F, Ricciardi S, Abrignani S, Pietrasanta C, Marasca F, Bodega B.
Sci Adv. 2024 Oct 11;10(41):eado2134. - Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals
Galeota E, Bevilacqua V, Gobbini A, Gruarin P, Bombaci M, Pesce E, Favalli A, Lombardi A, Vincenti F, Ongaro J, Fabbris T, Curti S, Martinovic M, Toccafondi M, Lorenzo M, Critelli A, Clemente F, Crosti M, Sarnicola ML, Martinelli M, La Sala L, Espadas A, Donnici L, Borghi MO, De Feo T, De Francesco R, Prati D, Meroni PL, Notarbartolo S, Geginat J, Gori A, Bandera A, Abrignani S, Grifantini R.
Clin Immunol. 2024 Feb 28;261:110164. - Characterization of human CD4+ EOMES+ GzmK+ T-cell subsets unveils an uncoupling of suppressive functions from IL-10-producing capacities
Pulvirenti N, Silvetri Y, Clemente F, Bosotti R, Carelli E, Moschetti G, Gruarin P, Vasco C, Crosti MC, Sarnicola ML, Valenti L, Prati D, Abrignani S, Geginat J.
Eur J Immunol. 2024 Feb 23:e2350675. - Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs
Rossi RL, Elia D, Torre O, Cassandro R, Caminati A, Bulgheroni E, Carelli E, Vasco C, Abrignani S, Geginat J, Harari S.
Am J Respir Cell Mol Biol. 2024 Feb;70(2):146-148. - Protocol for the detection of defined T cell clones in a heterogeneous cell population
Gobbini A, Bandera A, Grifantini R, Abrignani S, Notarbartolo S.
STAR Protoc. 2024 Mar 15;5(1):102787. - Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis
Pesce E, Bombaci M, Croci S, Bonacini M, Marvisi C, Ricordi C, Monti S, Muratore F, Abrignani S, Caporali R, Borghi MO, Salvarani C, Villiger PM, Grifantini R, Meroni PL.
Clin Exp Rheumatol. 2024 Jul;42(7):1317-1320. - Study Group for the Immunological Monitoring post Covid19 vaccination. A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study.
Fedele G, Schiavoni I, Trentini F, Leone P, Olivetta E, Fallucca A, Fiore S, Di Martino A, Abrignani S, Baldo V, Baldovin T, Bandera A, Clerici P, De Paschale M, Diaco F, Domnich A, Fortunato F, Giberti I, Gori A, Grifantini R, Lazzarotto T, Lodi V, Mastroianni CM, Prato R, Restivo V, Vitale F, Brusaferro S, Merler S, Palamara AT, Stefanelli P
Front Immunol. 2023 Nov 20;14:1272119. - SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype
Silvestri Y, Clemente F, Moschetti G, Maioli S, Carelli E, Espadas de Arias A, Torelli R, Longhi E, De Feo T, Crosti M, Sarnicola ML, Salvi M, Mantovani G, Arosio M, Bombaci M, Pesce E, Grifantini R, Abrignani S, Geginat J, Muller I.
Clin Immunol. 2023 Sep;254:109684. - An intestinal Th17 subset is associated with inflammation in Crohn’s Disease and activated by adherent-invasive Escherichia coli (AIEC)
Paroni M, Leccese G, Ranzani V, Moschetti G, Chiara M, Perillo F, Ferri S, Clemente F, Noviello D, Conforti FS, Ferrero S, Karnani B, Bosotti R, Vasco C, Curti S, Crosti MC, Gruarin P, Rossetti G, Conte MP, Vecchi M, Pagani M, Landini P, Facciotti F, Abrignani S, Caprioli F, Geginat J.
J Crohns Colitis. 2023 Jul 18:jjad119. - TMEM123 a key player in immune surveillance of colorectal cancer
Pesce E, Cordiglieri C, Bombaci M, Eppenberger-Castori S, Oliveto S, Manara C, Crosti M, Ercan C, Coto M, Gobbini A, Campagnoli S, Donnarumma T, Martinelli M, Bevilacqua V, De Camilli E, Gruarin P, Sarnicola ML, Cassinotti E, Baldari L, Viale G, Biffo S, Abrignani S, Terracciano LM, Grifantini R.
Front Immunol. 2023 Jun 23;14:1194087. - Eomesodermin-expressing type 1 regulatory (EOMES+ Tr1)-like T cells: Basic biology and role in immune-mediated diseases
Geginat J, Vasco C, Gruarin P, Bonnal R, Rossetti G, Silvestri Y, Carelli E, Pulvirenti N, Scantamburlo M, Moschetti G, Clemente F, Grassi F, Monticelli S, Pagani M, Abrignani S.
Eur J Immunol. 2023 May;53(5):e2149775.. - Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
Amodio V, Lamba S, Chilà R, Cattaneo CM, Mussolin B, Corti G, Rospo G, Berrino E, Tripodo C, Pisati F, Bartolini A, Aquilano MC, Marsoni S, Mauri G, Marchiò C, Abrignani S, Di Nicolantonio F, Germano G, Bardelli A.
Cancer Cell. 2023 Jan 9;41(1):196-209.e5. - Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
Miluzio A, Cuomo A, Cordiglieri C, Donnici L, Pesce E, Bombaci M, Conti M, Fasciani A, Terracciano L, Manganaro L, Toccafondi M, Scagliola A, Oliveto S, Ricciardi S, Grifantini R, De Francesco R, Abrignani S, Manfrini N, Biffo S.
EBioMedicine. 2023 Jan;87:104390. - Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study
Fedele G, Trentini F, Schiavoni I, Abrignani S, Antonelli G, Baldo V, Baldovin T, Bandera A, Bonura F, Clerici P, De Paschale M, Fortunato F, Gori A, Grifantini R, Icardi G, Lazzarotto T, Lodi V, Mastroianni CM, Orsi A, Prato R, Restivo V, Carsetti R, Piano Mortari E, Leone P, Olivetta E, Fiore S, Di Martino A, Brusaferro S, Merler S, Palamara AT, Stefanelli P.
Front Immunol. 2022 Oct 31;13:1021396. - Human T lymphocytes at tumor sites
Notarbartolo S, Abrignani S.
Semin Immunopathol. 2022 Nov;44(6):883-901. - Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
Borghi MO, Bombaci M, Bodio C, Lonati PA, Gobbini A, Lorenzo M, Torresani E, Dubini A, Bulgarelli I, Solari F, Pregnolato F, Bandera A, Gori A, Parati G, Abrignani S, Grifantini R, Meroni PL.
Front Immunol. 2022 Jul 15;13:930074. - Deep Phenotyping of T-Cells Derived From the Aneurysm Wall in a Pediatric Case of Subarachnoid Hemorrhage
Moschetti G, Vasco C, Clemente F, Galeota E, Carbonara M, Pluderi M, Locatelli M, Stocchetti N, Abrignani S, Zanier ER, Ortolano F, Zoerle T, Geginat J.
Front Immunol. 2022 May 31;13:866558. - Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Population
Favalli A, Favalli EG, Gobbini A, Zagato E, Bombaci M, Maioli G, Pesce E, Donnici L, Gruarin P, Biggioggero M, Curti S, Manganaro L, Marchisio E, Bevilacqua V, Martinovic M, Fabbris T, Sarnicola ML, Crosti MC, Marongiu L, Granucci F, Notarbartolo S, Bandera A, Gori A, De Francesco R, Abrignani S, Caporali R, Grifantini R.
Front Immunol. 2022 Jun 10;13:873195. - The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
Favalli EG, Gobbini A, Bombaci M, Maioli G, Biggioggero M, Pesce E, Favalli A, Martinovic M, Fabbris T, Marchisio E, Bandiera A, Gori A, Abrignani S, Grifantini R, Caporali R.
Front Med (Lausanne). 2022 Mar 11;9:850858. - Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors
Lenti E, Genovese L, Bianchessi S, Maurizio A, Sain SB, di Lillo A, Mattavelli G, Harel I, Bernassola F, Hehlgans T, Pfeffer K, Crosti M, Abrignani S, Evans SM, Sitia G, Guimarães-Camboa N, Russo V, van de Pavert SA, Garcia-Manteiga JM, Brendolan A.
Immunity. 2022 Apr 12;55(4):606-622.e6. - LINE1 elements are spliced in non-canonical transcript variants to control gene expression in human T cell quiescence and exhaustion
Marasca F, Sinha S, Vadalà R, Polimeni B, Ranzani V, Paraboschi E, Burattin FV, Ghilotti M, Crosti MC, Negri ML, Campagnoli S, Notarbartolo S, Bianchi AS, Siena S, Prati D, Montini G, Viale G, Torre O, Harari S, Grifantini R, Soldà G, Biffo S, Abrignani S, Bodega B.
Nat Genet. 2022 Feb;54(2):180-193. - Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
Pesce E, Manfrini N, Cordiglieri C, Santi S, Bandera A, Gobbini A, Gruarin P, Favalli A, Bombaci M, Cuomo A, Collino F, Cricrì G, Ungaro R, Lombardi A, Mangioni D, Muscatello A, Aliberti S, Blasi F, Gori A, Abrignani S, De Francesco R, Biffo S, Grifantini R.
Front Immunol. 2022 Jan 17;12:785941. - Pulmonary Langerhans cell histiocystosis (PLCH) and lymphangioleiomyomatosis (LAM) have circulating cells with loss of heterozygosity of the TSC2 gene
Elia D, Torre O, Vasco C, Geginat J, Abrignani S, Bulgheroni E, Carelli E, Cassandro R, Pacheco-Rodriguez G, Steagall WK, Moss J, Harari S.
Chest. 2022 Feb 26:S0012-3692(22)00398-1. - Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination
Lonati PA, Bodio C, Scavone M, Martini G, Pesce E, Bandera A, Lombardi A, Gerosa M, Franceschini F, Tincani A, Podda G, Abrignani S, Grifantini R, Cattaneo M, Borghi MO, Meroni PL.
RMD Open. 2022 Feb;8(1):e001902. - Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
Amatu A, Pani A, Patelli G, Gagliardi OM, Loparco M, Piscazzi D, Cassingena A, Tosi F, Ghezzi S, Campisi D, Grifantini R, Abrignani S, Siena S, Scaglione F, Sartore-Bianchi A.
Eur J Cancer. 2022 Mar;163:16-25. - Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study
Lombardi A, Butta GM, Donnici L, Bozzi G, Oggioni M, Bono P, Matera M, Consonni D, Ludovisi S, Muscatello A, Ceriotti F, Conti M, Scaglioni S, Gallo G, Scarpa E, Letko M, Abrignani S, Grifantini R, De Francesco R, Gori A, Manganaro L, Bandera A.
Lancet Reg Health Eur. 2022 Feb;13:100287. - Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing
Marongiu L, Protti G, Facchini FA, Valache M, Mingozzi F, Ranzani V, Putignano AR, Salviati L, Bevilacqua V, Curti S, Crosti M, Sarnicola ML, D’Angiò M, Bettini LR, Biondi A, Nespoli L, Tamini N, Clementi N, Mancini N, Abrignani S, Spreafico R, Granucci F.
Eur J Immunol. 2022 Jan;52(1):109-122.
- Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, Gobbini A, Galeota E, Manara C, Bombaci M, Pesce E, Zagato E, Favalli A, Sarnicola ML, Curti S, Crosti M, Martinovic M, Fabbris T, Marini F, Donnici L, Lorenzo M, Mancino M, Ungaro R, Lombardi A, Mangioni D, Muscatello A, Aliberti S, Blasi F, De Feo T, Prati D, Manganaro L, Granucci F, Lanzavecchia A, De Francesco R, Gori A, Grifantini R, Abrignani S.
Sci Immunol. 2021 Aug 10;6(62):eabg5021. - Clonally expanded EOMES+ Tr1-like cells in primary and metastatic tumors are associated with disease progression.
Bonnal RJP, Rossetti G, Lugli E, De Simone M, Gruarin P, Brummelman J, Drufuca L, Passaro M, Bason R, Gervasoni F, Della Chiara G, D’Oria C, Martinovic M, Curti S, Ranzani V, Cordiglieri C, Alvisi G, Mazza EMC, Oliveto S, Silvestri Y, Carelli E, Mazzara S, Bosotti R, Sarnicola ML, Godano C, Bevilacqua V, Lorenzo M, Siena S, Bonoldi E, Sartore-Bianchi A, Amatu A, Veronesi G, Novellis P, Alloisio M, Giani A, Zucchini N, Opocher E, Ceretti AP, Mariani N, Biffo S, Prati D, Bardelli A, Geginat J, Lanzavecchia A, Abrignani S, Pagani M.
Nat Immunol. 2021 May 20. doi: 10.1038/s41590-021-00930-4. Online ahead of print - High-dose vitamin C enhances cancer immunotherapy.
Magrì A, Germano G, Lorenzato A, Lamba S, Chilà R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, Abrignani S, D’Incalci M, Zucchetti M, Di Nicolantonio F, Bardelli A.
Sci Transl Med. 2020 Feb 26;12(532). pii: eaay8707. doi: 10.1126/scitranslmed.aay8707. - A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin
Arena S, Corti G, Durinikova E, Montone M, Reilly NM, Russo M, Lorenzato A, Arcella P, Lazzari L, Rospo G, Pagani M1, Cancelliere C, Negrino C, Isella C, Bartolini A, Cassingena A, Amatu A, Mauri G, Sartore-Bianchi A, Mittica G, Medico E, Marsoni S, Linnebacher M, Abrignani S, Siena S, Di Nicolantonio F, Bardelli A.
Clinical Cancer Research, 2019 Dec 12. pii: clincanres.2409.2019. doi: 10.1158/1078-0432.CCR-19-2409. [Epub ahead of print] - Novel biomarkers for Primary Biliary Cholangitis to improve diagnosis and understand underlying regulatory mechanisms.
Bombaci M, Pesce E, Torri A, Carpi D, Crosti M, Lanzafame M, Cordiglieri C, Sinisi A, Moro M, Bernuzzi F, Gerussi A, Geginat J, Muratori L, Terracciano LM, Invernizzi P, Abrignani S, Grifantini R.
Liver Int. 2019 Apr 29. doi: 10.1111/liv.14128. [Epub ahead of print] - Repression of miR-31 by BCL6 stabilizes the helper function of human follicular helper T cells.
Ripamonti A, Provasi E, Lorenzo M, De Simone M, Ranzani V, Vangelisti S, Curti S, Bonnal RJP, Pignataro L, Torretta S, Geginat J, Rossetti G, Pagani M, Abrignani S.
Proc Natl Acad Sci U S A. (2017) 114:12797-12802 - The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?
Geginat J, Paroni M, Pagani M, Galimberti D, De Francesco R, Scarpini E, Abrignani S.
Trends Immunol (2017) 38:498-512 - Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity.
Torri A, Carpi D, Bulgheroni E, Crosti MC, Moro M, Gruarin P, Rossi RL, Rossetti G, Di Vizio D, Hoxha M, Bollati V, Gagliani C, Tacchetti C, Paroni M, Geginat J, Corti L, Venegoni L, Berti E, Pagani M, Matarese G, Abrignani S, de Candia P.
J Biol Chem (2017) 292:2903-2915 - The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures.
de Candia P, Torri A, Fedeli M, Vigano V, Carpi D, Gorletta T, Casorati G, Pagani M, Dellabona P, Abrignani S.
Eur J Immunol (2016) 46:725-31 - Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.
De Simone M, Arrigoni A, Rossetti G, Gruarin P, Ranzani V, Politano C, Bonnal RJ, Provasi E, Sarnicola ML, Panzeri I, Moro M, Crosti M, Mazzara S, Vaira V, Bosari S, Palleschi A, Santambrogio L, Bovo G, Zucchini N, Totis M, Gianotti L, Cesana G, Perego RA, Maroni N, Pisani Ceretti A, Opocher E, De Francesco R, Geginat J, Stunnenberg HG, Abrignani S, Pagani M.
Immunity (2016) 45:1135-1147 - Reverse plasticity: TGF-beta and IL-6 induce Th1-to-Th17-cell transdifferentiation in the gut.
Geginat J, Paroni M, Kastirr I, Larghi P, Pagani M, Abrignani S.
Eur J Immunol (2016) 46:2306-2310 - Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets.
Geginat J, Nizzoli G, Paroni M, Maglie S, Larghi P, Pascolo S, Abrignani S.
Front Immunol (2015) 6:527 - The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4.
Ranzani V, Rossetti G, Panzeri I, Arrigoni A, Bonnal RJ, Curti S, Gruarin P, Provasi E, Sugliano E, Marconi M, De Francesco R, Geginat J, Bodega B, Abrignani S, Pagani M.
Nat Immunol (2015) 16:318-325 - Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease.
de Candia P, Torri A, Pagani M, Abrignani S.
Front Immunol (2014) 5:43 - Why is it so difficult to develop a hepatitis C virus preventive vaccine?
Zingaretti C, De Francesco R, Abrignani S.
Clin Microbiol Infect (2014) 20 Suppl 5:103-9 - Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b.
Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ, Birolo RS, Moro M, Crosti MC, Gruarin P, Maglie S, Marabita F, Mascheroni D, Parente V, Comelli M, Trabucchi E, De Francesco R, Geginat J, Abrignani S, Pagani M.
Nat Immunol (2011) 12:796-803